Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise

Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise

Abstract Background To investigate the long-term economic outcome of dapagliflozin versus metformin in Chinese patients with type 2 diabetes mellitus (T2DM) whose diet and exercise have not provided sufficient glycemic control. Methods An economic analysis of dapagliflozin versus metformin was condu...

Full description

Bibliographic Details
Main Authors: Hua Nian, Xu Wan, Jing Ma, Fu Jie, Bin Wu
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Cost-effectiveness
Dapagliflozin
Metformin
Type 2 diabetes mellitus
Chinese setting
Online Access:http://link.springer.com/article/10.1186/s12962-020-00208-w

Internet

http://link.springer.com/article/10.1186/s12962-020-00208-w

Similar Items